An update from Paradigm Biopharmaceuticals ( ($AU:PAR) ) is now available. Paradigm Biopharmaceuticals has completed a US$5 million drawdown under ...

PARAdiGM students will be assigned to individual UAB biomedical researchers based on their stated scientific interests. Each student will work in a different lab on a research project that is directly ...

How will AI reshape our universities, and what does the future hold for higher education? On 8 November, the 2025 World ...

The management of rectal cancer has undergone significant evolution over the past decade, with an increasing recognition that traditional surgery may not ...

New research challenges the prevailing hypothesis for how donor stem cell grafts cause graft-versus-host disease, or GVHD, and offers an alternative model that could guide development of novel ...

As it moves forward with plans to fully sequence the genomes of at least 1 million people across the U.S., the National Institutes of Health's (NIH's) All of Us study is changing the research paradigm ...

Eli Lilly believes community-based clinical trials are the wave of the future and is pushing sponsors to embrace the paradigm as a way to boost enrollment and diversity. “In the future, I think we’ll ...

Morphology addresses the structure and formation of words while inflectional paradigms represent the complete set of forms a lexeme may take to convey grammatical distinctions. In recent years, ...

The latest announcement is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has engaged Nordic Bioscience Clinical ...

Proprio, the surgical technology company pioneering AI-powered surgical intelligence, today announced a partnership with the Harms Study Group (HSG), a global network of distinguished surgeons ...